Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Trillium Therapeutic (TRIL)

Trillium Therapeutic (TRIL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,813,300
  • Shares Outstanding, K 104,815
  • Annual Sales, $ 150 K
  • Annual Income, $ -59,350 K
  • 60-Month Beta 2.21
  • Price/Sales 12,344.09
  • Price/Cash Flow N/A
  • Price/Book 7.47
Trade TRIL with:

Options Overview

Details
  • Implied Volatility 20.29%
  • Historical Volatility 365.76%
  • IV Percentile 4%
  • IV Rank 3.29%
  • IV High 172.34% on 03/15/21
  • IV Low 15.12% on 09/03/21
  • Put/Call Vol Ratio 2.28
  • Today's Volume 8,419
  • Volume Avg (30-Day) 9,531
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 108,119
  • Open Int (30-Day) 70,777

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.19
  • Number of Estimates 2
  • High Estimate -0.17
  • Low Estimate -0.20
  • Prior Year -0.07
  • Growth Rate Est. (year over year) -171.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.80 +198.97%
on 08/20/21
17.76 -2.36%
on 08/23/21
+11.09 (+177.44%)
since 08/17/21
3-Month
5.80 +198.97%
on 08/20/21
17.76 -2.36%
on 08/23/21
+7.41 (+74.62%)
since 06/17/21
52-Week
5.80 +198.97%
on 08/20/21
20.96 -17.27%
on 11/30/20
+1.95 (+12.67%)
since 09/17/20

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADTN, DSPG, LMRK, TRIL; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

TRIL : 17.34 (+0.23%)
ADTN : 19.05 (-2.01%)
DSPG : 21.74 (-0.46%)
LMRK : 16.52 (-0.24%)
New Strong Sell Stocks for September 15th

ARCE, NSSC, PAGP, TRIL, and VALE have been added to the Zacks Rank #5 (Strong Sell) List on September 15, 2021.

VALE : 16.31 (-2.45%)
PAGP : 10.15 (-3.24%)
NSSC : 41.30 (-1.17%)
TRIL : 17.34 (+0.23%)
ARCE : 23.37 (+0.17%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds DSPG, ADTN, TRIL, and STMP Shareholders About Its Ongoing Investigations

/PRNewswire/ --

DSPG : 21.74 (-0.46%)
ADTN : 19.05 (-2.01%)
TRIL : 17.34 (+0.23%)
STMP : 328.70 (-0.05%)
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Trillium Therapeutics, Inc. - TRIL

/PRNewswire/ -- , founder and managing partner at , a national securities firm rated in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in ,...

TRIL : 17.34 (+0.23%)
INVESTIGATION: Halper Sadeh LLP Investigates INOV, SAFM, LMRK, AVCO, TRIL, XENT; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

INOV : 40.39 (-0.05%)
SAFM : 190.91 (+0.26%)
LMRK : 16.52 (-0.24%)
AVCO : 0.9400 (+4.44%)
TRIL : 17.34 (+0.23%)
XENT : 27.25 (-0.26%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds DSPG, ADTN, TRIL, and SIC Shareholders About Its Ongoing Investigations

/PRNewswire/ --

DSPG : 21.74 (-0.46%)
ADTN : 19.05 (-2.01%)
TRIL : 17.34 (+0.23%)
SIC : 14.47 (+0.28%)
Lifshitz Law Firm, P.C. Announces Investigation of XENT, LMRK, TGRF, and TRIL

NEW YORK, NY / ACCESSWIRE / August 30, 2021 / Lifshitz Law Firm, P.C.

XENT : 27.25 (-0.26%)
LMRK : 16.52 (-0.24%)
TGRF : 14.7500 (unch)
TRIL : 17.34 (+0.23%)
Lifshitz Law Firm, P.C. Announces Investigation of FFWM, JAX, LMRK, and TRIL

NEW YORK, NY / ACCESSWIRE / August 26, 2021 /

FFWM : 24.88 (+1.22%)
JAX : 13.94 (unch)
LMRK : 16.52 (-0.24%)
TRIL : 17.34 (+0.23%)
Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs

Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.

JNJ : 164.75 (-0.28%)
PFE : 43.89 (-1.30%)
MRNA : 430.05 (-2.41%)
BIB : 106.80 (+1.07%)
TRIL : 17.34 (+0.23%)
LABU : 66.17 (+4.65%)
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Trillium Therapeutics Inc. (Nasdaq - TRIL)

BALA CYNWYD, PA / ACCESSWIRE / August 24, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Trillium Therapeutics Inc. ("Trillium"...

PFE : 43.89 (-1.30%)
TRIL : 17.34 (+0.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The company's lead program, SIRPaFc (TTI-621), is a fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin...

See More

Key Turning Points

3rd Resistance Point 17.53
2nd Resistance Point 17.45
1st Resistance Point 17.39
Last Price 17.34
1st Support Level 17.25
2nd Support Level 17.17
3rd Support Level 17.11

See More

52-Week High 20.96
Last Price 17.34
Fibonacci 61.8% 15.17
Fibonacci 50% 13.38
Fibonacci 38.2% 11.59
52-Week Low 5.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar